21-33070938-A-C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_138983.3(OLIG1):​c.692A>C​(p.Gln231Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,455,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q231K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

OLIG1
NM_138983.3 missense

Scores

2
1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.17

Publications

0 publications found
Variant links:
Genes affected
OLIG1 (HGNC:16983): (oligodendrocyte transcription factor 1) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in neuron differentiation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within neuron fate commitment. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14124241).
BS2
High AC in GnomAd4 at 22 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138983.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OLIG1
NM_138983.3
MANE Select
c.692A>Cp.Gln231Pro
missense
Exon 1 of 1NP_620450.2Q8TAK6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OLIG1
ENST00000382348.2
TSL:6 MANE Select
c.692A>Cp.Gln231Pro
missense
Exon 1 of 1ENSP00000371785.1Q8TAK6
ENSG00000227757
ENST00000454622.2
TSL:2
n.167T>G
non_coding_transcript_exon
Exon 1 of 2
ENSG00000227757
ENST00000777421.1
n.57T>G
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
151730
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000104
AC:
7
AN:
67584
AF XY:
0.000126
show subpopulations
Gnomad AFR exome
AF:
0.00127
Gnomad AMR exome
AF:
0.0000789
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000199
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000229
AC:
299
AN:
1303612
Hom.:
0
Cov.:
32
AF XY:
0.000227
AC XY:
146
AN XY:
642308
show subpopulations
African (AFR)
AF:
0.0000770
AC:
2
AN:
25982
American (AMR)
AF:
0.0000427
AC:
1
AN:
23420
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22416
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27878
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70882
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3838
European-Non Finnish (NFE)
AF:
0.000269
AC:
281
AN:
1042916
Other (OTH)
AF:
0.000278
AC:
15
AN:
53880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
151836
Hom.:
0
Cov.:
32
AF XY:
0.0000943
AC XY:
7
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41496
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5132
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10458
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
67878
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000174

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
17
DANN
Benign
0.61
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.45
T
M_CAP
Pathogenic
0.97
D
MetaRNN
Benign
0.14
T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Benign
0.0
N
PhyloP100
1.2
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
0.77
N
REVEL
Benign
0.24
Sift
Benign
0.15
T
Sift4G
Benign
0.33
T
Polyphen
0.013
B
Vest4
0.26
MutPred
0.35
Gain of disorder (P = 0.0396)
MVP
0.83
MPC
1.7
ClinPred
0.029
T
GERP RS
3.5
PromoterAI
0.050
Neutral
Varity_R
0.21
gMVP
0.43
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs902873632; hg19: chr21-34443244; API